CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 58 filers reported holding CTI BIOPHARMA CORP in Q3 2021. The put-call ratio across all filers is 2.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,205,590 | -21.9% | 1,953,712 | +11.8% | 0.08% | -9.2% |
| Q4 2022 | $10,503,076 | +35.7% | 1,747,600 | +31.5% | 0.09% | +33.8% |
| Q3 2022 | $7,738,000 | +52.9% | 1,329,476 | +56.8% | 0.06% | +32.7% |
| Q2 2022 | $5,060,000 | +417.4% | 847,700 | +304.4% | 0.05% | +444.4% |
| Q1 2022 | $978,000 | +130.7% | 209,600 | +22.4% | 0.01% | +125.0% |
| Q4 2021 | $424,000 | +89.3% | 171,200 | +125.3% | 0.00% | +100.0% |
| Q3 2021 | $224,000 | +16.1% | 76,000 | -1.3% | 0.00% | 0.0% |
| Q2 2021 | $193,000 | +65.0% | 77,000 | +90.0% | 0.00% | +100.0% |
| Q1 2021 | $117,000 | -19.3% | 40,526 | -10.1% | 0.00% | -50.0% |
| Q4 2020 | $145,000 | – | 45,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,800,358 | $21,825,000 | 10.02% |
| CAXTON CORP | 2,239,300 | $5,553,000 | 4.54% |
| Altium Capital Management LP | 2,185,000 | $5,419,000 | 1.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,483,829 | $3,680,000 | 1.49% |
| Ghost Tree Capital, LLC | 1,200,000 | $2,976,000 | 1.07% |
| Lion Point Capital, LP | 1,223,595 | $3,034,000 | 0.81% |
| BVF INC/IL | 8,929,690 | $22,146,000 | 0.80% |
| NEA Management Company, LLC | 7,140,450 | $17,708,000 | 0.36% |
| Knott David M Jr | 221,079 | $548,000 | 0.19% |
| Lakeside Advisors, INC. | 97,780 | $242,000 | 0.18% |